Which limits apply for Nitrosamines in medicinal products?

  Рет қаралды 3,498

Pharma Growth Hub

Pharma Growth Hub

Күн бұрын

Пікірлер: 5
@harikrishna851
@harikrishna851 Жыл бұрын
Thank you for your time and efforts
@sambhajimasal4248
@sambhajimasal4248 Жыл бұрын
Thank you so much sir,❤
@krupa.b8153
@krupa.b8153 7 ай бұрын
Do we need to combine general nitrosamines and NDSRIs while setting specification limit ( considering most potent one) .please suggest
@krushnapalraol8705
@krushnapalraol8705 Жыл бұрын
Dear sir, In many websites like drug bank, they give two pKa values of drug like as pKa (Strongest acidic) and pKa(Strongest basic). So for LCMSMS method development which one will consider ?
@pawankittuaahan
@pawankittuaahan 11 ай бұрын
Hi sir sorry to say that this video is informative only. You did not tried to explain the calculation.
How to Define Limit For Newly Identified Nitrosamine Impurity?
17:16
Pharma Growth Hub
Рет қаралды 9 М.
5 WHYS | WHY WHY | SIMPLIFIED!
17:30
Pharma Growth Hub
Рет қаралды 3,2 М.
How to treat Acne💉
00:31
ISSEI / いっせい
Рет қаралды 108 МЛН
Don’t Choose The Wrong Box 😱
00:41
Topper Guild
Рет қаралды 62 МЛН
Can less than lifetime be applied for nitrosamines?
7:22
Fernanda Waechter
Рет қаралды 3,1 М.
How to define limit for unknown, known and total impurities
26:07
Pharma Growth Hub
Рет қаралды 61 М.
Arenediazonium Salts With Diazo Coupling and Sandmeyer Reactions
18:46
The Organic Chemistry Tutor
Рет қаралды 53 М.
How to predict the potency category of Nitrosamine as per new EMA updates
9:13
How to use CPCA to define AI Limit of Nitrosamine?
26:42
Pharma Growth Hub
Рет қаралды 3,7 М.
Mutagenic Impurities from a Drug Substance Perspective: Highlights from ICH M7 Q&A Draft Document
12:22
How to Build Effective AI Agents (without the hype)
24:27
Dave Ebbelaar
Рет қаралды 95 М.
How to treat Acne💉
00:31
ISSEI / いっせい
Рет қаралды 108 МЛН